US Stocks
/
Akebia Therapeutics, Inc. Share Price

Akebia Therapeutics, Inc. Share Price

NASDAQ: AKBA | Micro Cap
$0.82
-$0.06 (-6.68%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Akebia Therapeutics, Inc. Stock Performance

Open
$0.85
Prev. Close
$0.88
Circuit Range
N/A
Day Range
$0.81 - $0.86
Year Range
$0.81 - $3.18
Volume
1,13,930
Average Traded
$0.83

Akebia Therapeutics, Inc. Share Price Today

As of 9 October 2026, Akebia Therapeutics, Inc.'s share price is $0.82. The stock opened at $0.85, compared to its previous close of $0.88. During today's trading session, Akebia Therapeutics, Inc.'s share price traded between $0.81 and $0.86, with an average price of $0.84. Over the past 52 weeks, the stock has recorded a high of $3.18 and a low of $0.81. In terms of performance, Akebia Therapeutics, Inc.'s share price has declined by 41.04% over the last six months and is down 62.97% on a year-on-year basis.

Akebia Therapeutics, Inc. Share Price Chart

$0.81$0.86
L
Show Current Price
H

Akebia Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$210.00M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.11
Revenue (TTM)
$236.20B
Return On Equity (TTM)
-118.58%
Profit Margin
-2.27%
Debt to Equity
1.98
Quarterly Earnings Growth YoY
-1750.00%

Akebia Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$58.77$57.62$53.54$49.13
Net Profit$0.54-$12.24-$9.05-$8.91
Net Profit Margin0.92%-21.24%-16.90%-18.14%
Income ChangeN/A-2366.67%26.06%1.55%

Akebia Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$292.48$194.62$160.18$236.20
Net Profit-$94.23-$51.93-$69.41-$5.35
Net Profit Margin-32.22%-26.68%-43.33%-2.27%
Income ChangeN/A44.89%-33.66%92.29%

About Akebia Therapeutics, Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

Akebia Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.91
$0.82
-11.18%
Sep 2026
$0.92
$0.92
-1.92%
Aug 2026
$1.32
$0.94
-29.13%
Jul 2026
$1.16
$1.32
+17.78%
Jun 2026
$1.02
$1.13
+9.76%
May 2026
$1.40
$1.02
-25.99%
Apr 2026
$1.41
$1.39
-0.36%
Mar 2026
$1.28
$1.39
+5.30%
Feb 2026
$1.39
$1.32
-6.38%
Jan 2026
$1.60
$1.41
-12.15%
Dec 2025
$1.59
$1.60
+1.58%
Nov 2025
$2.19
$1.58
-28.34%

AKBA Share Price FAQs

What is Akebia Therapeutics, Inc. share price today?

chevron-up
Akebia Therapeutics, Inc. share price today is $0.82 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Akebia Therapeutics, Inc. stock?

chevron-up
The 52 week high of Akebia Therapeutics, Inc. stock is $3.18, while the 52 week low is $0.81 as of 9 Oct '26.

What is AKBA's market capitalisation today?

chevron-up
AKBA market capitalisation is $210.00M as of October 9, 2026, at 4:47 pm IST.

What is AKBA's net income for the last quarter?

chevron-up
AKBA's net income for the last quarter is -8.91B USD.

What is the 5 year returns of AKBA?

chevron-up
The 5 year returns of AKBA is -71.50% as on 9 Oct '26.

What is the high & low stock price of AKBA today?

chevron-up
AKBA stock price hit a high of $0.86 and low of $0.81 as of 9 Oct '26.

Can I buy AKBA shares in India?

chevron-up
Yes. You can buy AKBA in India by opening an international trading account.